These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1483641)

  • 21. Prescription-drug prices.
    Frank RG
    N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294
    [No Abstract]   [Full Text] [Related]  

  • 22. An Rx for reform: a Medicare prescription drug benefit.
    Rak J
    Health Matrix Clevel; 2002; 12(2):449-505. PubMed ID: 12430363
    [No Abstract]   [Full Text] [Related]  

  • 23. And on the cover of the guide were two words in red--don't panic.
    Harvey R
    Aust Health Rev; 2001; 24(2):15-20. PubMed ID: 11496457
    [No Abstract]   [Full Text] [Related]  

  • 24. Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry.
    Bloor K; Maynard A; Freemantle N
    BMJ; 1996 Jul; 313(7048):33-5. PubMed ID: 8664771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crossing boundaries. Big Pharma stalls discounted Maine Rx drug program.
    White C
    Revolution (Oakl); 2002; 3(6):9. PubMed ID: 12599702
    [No Abstract]   [Full Text] [Related]  

  • 26. The placebo effect. Congress hopes you won't notice its prescription-drug plans are meant to help candidates, not patients.
    Tumulty K
    Time; 2002 Aug; 160(7):26. PubMed ID: 12195650
    [No Abstract]   [Full Text] [Related]  

  • 27. Senate GOP tosses drug bill. Law would have let Medicare negotiate costs directly.
    DoBias M
    Mod Healthc; 2007 Apr; 37(17):12. PubMed ID: 17479495
    [No Abstract]   [Full Text] [Related]  

  • 28. Riding high on a drug bill.
    Harrington A
    Fortune; 2003 Sep; 148(4):168. PubMed ID: 12964298
    [No Abstract]   [Full Text] [Related]  

  • 29. Lilly purchase of PCS awaits FTC clearance.
    Scott L
    Mod Healthc; 1994 Oct; 24(44):29. PubMed ID: 10138146
    [No Abstract]   [Full Text] [Related]  

  • 30. Lilly deal's timing drew FTC notice.
    Scott L
    Mod Healthc; 1994 Oct; 24(43):8. PubMed ID: 10138136
    [No Abstract]   [Full Text] [Related]  

  • 31. Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.
    Sinha MS; Curfman GD; Carrier MA
    JAMA; 2018 Jun; 319(22):2271-2272. PubMed ID: 29801104
    [No Abstract]   [Full Text] [Related]  

  • 32. Bitter pills.
    Carpenter D
    Hosp Health Netw; 2000 Aug; 74(8):48-52. PubMed ID: 10983224
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of the state as a drug purchaser.
    Palumbo FB
    Food Drug Law J; 2001; 56(3):267-80. PubMed ID: 11944639
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-effectiveness guidelines. The experience of Australian manufacturers.
    Gorham P
    Pharmacoeconomics; 1995 Nov; 8(5):369-73. PubMed ID: 10160071
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.
    Henry DA; Hill SR; Harris A
    JAMA; 2005 Nov; 294(20):2630-2. PubMed ID: 16304078
    [No Abstract]   [Full Text] [Related]  

  • 36. Support for trials of promising medications through the Pharmaceutical Benefits Scheme. A proposal for a new authority category.
    Glasziou PP
    Med J Aust; 1995 Jan; 162(1):33-6. PubMed ID: 7605432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Making medicines affordable: the price factor (position paper).
    American Public Health Association
    Am J Public Health; 2001 Mar; 91(3):486-90. PubMed ID: 11236429
    [No Abstract]   [Full Text] [Related]  

  • 38. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
    Hamilton C; Lokuge B; Denniss R
    Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharma APMs: Can the Industry Learn To Play Well With Others?
    Alston M; Pyenson B
    Manag Care; 2018 Sep; 27(9):31-32. PubMed ID: 30216160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doubts emerge about drug industry mergers.
    Bus Health; 1994 Nov; 12(11):53-4, 56, 61. PubMed ID: 10138536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.